Revance Therapeutics, Inc. RVNC
Set alert
3.65 0.00 0.00%
At close · Feb 6
3.65 Day range 3.65
52-week range unavailable
- YTD
- +20.07%
- 1 year
- -39.37%
- Open
- 3.65
- Prev close
- 3.65
- Mkt cap
- 320.48M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.65
- High
- 3.65
- Forward P/E
- -3.23
- Beta
- 0.95
- Short ratio
- 5.20
- Inst. own
- 82.89%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.37
- 200-d avg
- 4.37
- 1y target
- 7.64
1Y chart
Price, volume, indicators and comparisons
Events in this range
- Feb 28, 2024Earnings: -0.62; estimate -0.79; surprise 21.52%
- May 9, 2024Earnings: -0.54; estimate -0.66; surprise 18.18%
- Aug 8, 2024Earnings: -0.36; estimate -0.48; surprise 25%
- Sep 13, 2024Downgrade: Barclays · Overweight → Equal-Weight
- Oct 28, 2024Rating: Needham · — → Hold
- Nov 7, 2024Earnings: -0.37; estimate -0.35; surprise -5.71%
- Nov 8, 2024Rating: HC Wainwright & Co. · Neutral → Neutral
- Nov 8, 2024Rating: Needham · — → Hold
- Dec 10, 2024Rating: Mizuho · Neutral → Neutral
- Dec 23, 2024Rating: Barclays · Equal-Weight → Equal-Weight
Signals (38)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 19, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 10, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 3, 2024 | 1 year ago |
| SMA: Bearish | Nov 8, 2024 | 1 year ago |
| SMA: Bearish | Nov 8, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 8, 2024 | 1 year ago |
| RSI: Oversold | Nov 8, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 28, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 25, 2024 | 2 years ago |
| RSI: Oversold | Oct 25, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 17, 2024 | 2 years ago |
| SMA: Bearish | Sep 25, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 29, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 12, 2024 | 2 years ago |
| RSI: Overbought | Aug 12, 2024 | 2 years ago |
| SMA: Bullish | Aug 9, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 31, 2024 | 2 years ago |
| RSI: Overbought | Jul 15, 2024 | 2 years ago |
| SMA: Bullish | Jul 11, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 28, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 25, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| RSI: Oversold | May 23, 2024 | 2 years ago |
| MACD: Sell Signal | May 15, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 30, 2024 | 2 years ago |
| RSI: Oversold | Apr 19, 2024 | 2 years ago |
| RSI: Oversold | Apr 16, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 14, 2024 | 2 years ago |
| SMA: Bearish | Mar 13, 2024 | 2 years ago |
| SMA: Bullish | Mar 11, 2024 | 2 years ago |
| SMA: Bearish | Mar 6, 2024 | 2 years ago |
| SMA: Bullish | Mar 5, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Feb 29, 2024 | 2 years ago |
Compare RVNC
Chart and line up RVNC against other symbols or a saved comparison set.
- RVNC Revance Therapeutics, Inc.
3.65
0.00 0.00%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | RVNC | SPY | QQQ |
|---|---|---|---|
| Last price | 3.65 | 755.72 | 690.49 |
| Change | 0.00 | -13.64 | -24.85 |
| Change % | 0.00% | -1.77% | -3.47% |
| Open | 3.65 | 761.38 | 697.13 |
| Day high | 3.65 | 761.46 | 698.63 |
| Day low | 3.65 | 750.36 | 683.45 |
| Previous close | 3.65 | 769.36 | 715.34 |
| Volume | 0 | 77.70M | 85.24M |
| Average volume | 0 | 41.22M | 34.57M |
| Market cap | 320.48M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | 0.00 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 0.00 | 779.09 | 759.66 |
| 52-week low | 0.00 | 631.97 | 558.28 |
| 1-week return | +0.274725% | -0.559233% | -1.97% |
| 1-month return | +18.12% | -0.906075% | -6.66% |
| 3-month return | -37.50% | +1.89% | +1.02% |
| 6-month return | +19.28% | +5.16% | +3.41% |
| Year-to-date return | +20.07% | +10.82% | +12.40% |
| 1-year return | -39.37% | +11.16% | +10.29% |
| 2-year return | -39.37% | +32.90% | +42.71% |
| 50-day moving average | 0.00 | 767.63 | 725.41 |
| 200-day moving average | 0.00 | 728.53 | 679.17 |
| Target price | 7.64 | — | — |
| Beta | 0.953 | 0.00 | 0.00 |
| Short ratio | 5.20 | — | — |
| Institutional ownership | 82.89% | — | — |